$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,329 | 99,184 | 170,437 | 171.8 K to 170.4 K (-0.77 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 101 | 7,538 | 50,601 | 50.7 K to 50.6 K (-0.20 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,485 | 110,827 | 185,548 | 187 K to 185.5 K (-0.79 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 90,251 | 6,695,487 | 8,586,759 | 8.7 M to 8.6 M (-1.04 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 13,856 | 1,027,941 | 1,359,780 | 1.4 M to 1.4 M (-1.01 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 2,388 | 177,160 | 266,675 | 269.1 K to 266.7 K (-0.89 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 1,385 | 102,750 | 171,766 | 173.2 K to 171.8 K (-0.80 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 106 | 7,864 | 50,702 | 50.8 K to 50.7 K (-0.21 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 1,547 | 114,768 | 187,033 | 188.6 K to 187 K (-0.82 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 413 | 30,795 | 8,677,010 | 8.7 M to 8.7 M (0.00 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 63 | 4,698 | 1,373,636 | 1.4 M to 1.4 M (0.00 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 11 | 820 | 269,063 | 269.1 K to 269.1 K (0.00 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 6 | 447 | 173,151 | 173.2 K to 173.2 K (0.00 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 7 | 522 | 188,580 | 188.6 K to 188.6 K (0.00 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 42,124 | 3,138,238 | 8,677,423 | 8.7 M to 8.7 M (-0.48 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 6,467 | 481,792 | 1,373,699 | 1.4 M to 1.4 M (-0.47 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 1,115 | 83,068 | 269,074 | 270.2 K to 269.1 K (-0.41 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 647 | 48,202 | 173,157 | 173.8 K to 173.2 K (-0.37 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 49 | 3,651 | 50,808 | 50.9 K to 50.8 K (-0.10 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 722 | 53,789 | 188,587 | 189.3 K to 188.6 K (-0.38 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 3,068 | 234,915 | 8,719,547 | 8.7 M to 8.7 M (-0.04 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 471 | 36,064 | 1,380,166 | 1.4 M to 1.4 M (-0.03 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 81 | 6,202 | 270,189 | 270.3 K to 270.2 K (-0.03 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 47 | 3,599 | 173,804 | 173.9 K to 173.8 K (-0.03 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 4 | 306 | 50,857 | 50.9 K to 50.9 K (-0.01 %) |
| Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 52 | 3,982 | 189,309 | 189.4 K to 189.3 K (-0.03 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 1,648 | 125,301 | 8,722,615 | 8.7 M to 8.7 M (-0.02 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 253 | 19,236 | 1,380,637 | 1.4 M to 1.4 M (-0.02 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 44 | 3,345 | 270,270 | 270.3 K to 270.3 K (-0.02 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 25 | 1,901 | 173,851 | 173.9 K to 173.9 K (-0.01 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 2 | 152 | 50,861 | 50.9 K to 50.9 K (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.03 | 28 | 2,129 | 189,361 | 189.4 K to 189.4 K (-0.01 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 51,987 | 3,977,031 | 8,724,263 | 8.8 M to 8.7 M (-0.59 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 7,982 | 610,627 | 1,380,890 | 1.4 M to 1.4 M (-0.57 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 1,375 | 105,188 | 270,314 | 271.7 K to 270.3 K (-0.51 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 798 | 61,047 | 173,876 | 174.7 K to 173.9 K (-0.46 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 61 | 4,667 | 50,863 | 50.9 K to 50.9 K (-0.12 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.50 | 891 | 68,162 | 189,389 | 190.3 K to 189.4 K (-0.47 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 247 | 18,624 | 8,776,250 | 8.8 M to 8.8 M (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 39 | 2,941 | 1,388,872 | 1.4 M to 1.4 M (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 7 | 528 | 271,689 | 271.7 K to 271.7 K (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 4 | 302 | 174,674 | 174.7 K to 174.7 K (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 1 | 75 | 50,924 | 50.9 K to 50.9 K (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.40 | 4 | 302 | 190,280 | 190.3 K to 190.3 K (0.00 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 63,047 | 4,786,390 | 8,776,497 | 8.8 M to 8.8 M (-0.71 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 9,679 | 734,808 | 1,388,911 | 1.4 M to 1.4 M (-0.69 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 1,668 | 126,631 | 271,696 | 273.4 K to 271.7 K (-0.61 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 967 | 73,413 | 174,678 | 175.6 K to 174.7 K (-0.55 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 73 | 5,542 | 50,925 | 51 K to 50.9 K (-0.14 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.92 | 1,080 | 81,991 | 190,284 | 191.4 K to 190.3 K (-0.56 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 2,832 | 215,369 | 8,839,544 | 8.8 M to 8.8 M (-0.03 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 435 | 33,081 | 1,398,590 | 1.4 M to 1.4 M (-0.03 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 75 | 5,704 | 273,364 | 273.4 K to 273.4 K (-0.03 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 43 | 3,270 | 175,645 | 175.7 K to 175.6 K (-0.02 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 3 | 228 | 50,998 | 51 K to 51 K (-0.01 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.05 | 49 | 3,726 | 191,364 | 191.4 K to 191.4 K (-0.03 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 61,122 | 4,622,669 | 8,842,376 | 8.9 M to 8.8 M (-0.69 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 9,384 | 709,714 | 1,399,025 | 1.4 M to 1.4 M (-0.67 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 1,618 | 122,370 | 273,439 | 275.1 K to 273.4 K (-0.59 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 938 | 70,941 | 175,688 | 176.6 K to 175.7 K (-0.53 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 71 | 5,370 | 51,001 | 51.1 K to 51 K (-0.14 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.63 | 1,047 | 79,185 | 191,413 | 192.5 K to 191.4 K (-0.54 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 10,000 | 229,800 | 16,424 | |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 21,471 | |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 75.82 | 2,100 | 159,215 | 43,722 | 45.8 K to 43.7 K (-4.58 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 74.98 | 7,900 | 592,317 | 45,822 | 53.7 K to 45.8 K (-14.71 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 75.81 | 1,000 | 75,805 | 53,722 | 54.7 K to 53.7 K (-1.83 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 74.98 | 4,000 | 299,936 | 54,722 | 58.7 K to 54.7 K (-6.81 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 10,000 | 229,800 | 58,722 | 48.7 K to 58.7 K (+20.52 %) |
| Mar 14 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 48,722 | 43.7 K to 48.7 K (+11.44 %) |
| Mar 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 73.71 | 847 | 62,434 | 125,952 | 126.8 K to 126 K (-0.67 %) |
| Mar 12 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 73.18 | 9,153 | 669,804 | 126,799 | 136 K to 126.8 K (-6.73 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 22,897 | |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 74.77 | 200 | 14,953 | 22,790 | 23 K to 22.8 K (-0.87 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 74.03 | 2,200 | 162,871 | 22,990 | 25.2 K to 23 K (-8.73 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 72.95 | 600 | 43,772 | 25,190 | 25.8 K to 25.2 K (-2.33 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 25,790 | 22.8 K to 25.8 K (+13.16 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 3,296 | 244,007 | 8,903,498 | 8.9 M to 8.9 M (-0.04 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 506 | 37,460 | 1,408,409 | 1.4 M to 1.4 M (-0.04 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 87 | 6,441 | 275,057 | 275.1 K to 275.1 K (-0.03 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 51 | 3,776 | 176,626 | 176.7 K to 176.6 K (-0.03 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 4 | 296 | 51,072 | 51.1 K to 51.1 K (-0.01 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.03 | 56 | 4,146 | 192,460 | 192.5 K to 192.5 K (-0.03 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 37,107 | 2,786,101 | 8,906,794 | 8.9 M to 8.9 M (-0.41 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 5,697 | 427,747 | 1,408,915 | 1.4 M to 1.4 M (-0.40 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 982 | 73,731 | 275,144 | 276.1 K to 275.1 K (-0.36 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 569 | 42,722 | 176,677 | 177.2 K to 176.7 K (-0.32 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 43 | 3,229 | 51,076 | 51.1 K to 51.1 K (-0.08 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.08 | 637 | 47,828 | 192,516 | 193.2 K to 192.5 K (-0.33 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 18,703 | 1,375,551 | 8,943,901 | 9 M to 8.9 M (-0.21 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 2,872 | 211,227 | 1,414,612 | 1.4 M to 1.4 M (-0.20 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 495 | 36,406 | 276,126 | 276.6 K to 276.1 K (-0.18 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 287 | 21,108 | 177,246 | 177.5 K to 177.2 K (-0.16 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 22 | 1,618 | 51,119 | 51.1 K to 51.1 K (-0.04 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.55 | 321 | 23,609 | 193,153 | 193.5 K to 193.2 K (-0.17 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 1,647 | 121,421 | 8,962,604 | 9 M to 9 M (-0.02 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 253 | 18,652 | 1,417,484 | 1.4 M to 1.4 M (-0.02 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 44 | 3,244 | 276,621 | 276.7 K to 276.6 K (-0.02 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 25 | 1,843 | 177,533 | 177.6 K to 177.5 K (-0.01 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 2 | 147 | 51,141 | 51.1 K to 51.1 K (0.00 %) |
| Mar 11 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.72 | 29 | 2,138 | 193,474 | 193.5 K to 193.5 K (-0.01 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | S | 28.05 | 5,000 | 140,250 | 32,500 | |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.18 | 20,000 | 343,600 | 0 | |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.18 | 25,000 | 429,500 | 20,000 | |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 77.22 | 4,798 | 370,489 | 335,479 | 340.3 K to 335.5 K (-1.41 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.41 | 14,900 | 1,138,536 | 340,277 | 355.2 K to 340.3 K (-4.20 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 75.62 | 5,302 | 400,948 | 355,177 | 360.5 K to 355.2 K (-1.47 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 28.05 | 5,000 | 140,250 | 360,479 | 355.5 K to 360.5 K (+1.41 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.18 | 20,000 | 343,600 | 355,479 | 335.5 K to 355.5 K (+5.96 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 77.29 | 2,193 | 169,497 | 335,479 | 337.7 K to 335.5 K (-0.65 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.53 | 22,807 | 1,745,326 | 337,672 | 360.5 K to 337.7 K (-6.33 %) |
| Mar 01 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.18 | 25,000 | 429,500 | 360,479 | 335.5 K to 360.5 K (+7.45 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 493 | 37,565 | 9,060,972 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 76 | 5,791 | 1,432,586 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 279,226 | 279.2 K to 279.2 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 8 | 610 | 179,043 | 179.1 K to 179 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,256 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 9 | 686 | 195,161 | 195.2 K to 195.2 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 742 | 56,540 | 9,061,465 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 114 | 8,687 | 1,432,662 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 20 | 1,524 | 279,239 | 279.3 K to 279.2 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 11 | 838 | 179,051 | 179.1 K to 179.1 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,257 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 195,170 | 195.2 K to 195.2 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 31,482 | 2,413,501 | 9,062,207 | 9.1 M to 9.1 M (-0.35 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 4,833 | 370,512 | 1,432,776 | 1.4 M to 1.4 M (-0.34 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 833 | 63,860 | 279,259 | 280.1 K to 279.3 K (-0.30 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 484 | 37,105 | 179,062 | 179.5 K to 179.1 K (-0.27 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 37 | 2,837 | 51,258 | 51.3 K to 51.3 K (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 539 | 41,321 | 195,183 | 195.7 K to 195.2 K (-0.28 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 620 | 48,239 | 9,093,689 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 95 | 7,392 | 1,437,609 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 16 | 1,245 | 280,092 | 280.1 K to 280.1 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 10 | 778 | 179,546 | 179.6 K to 179.5 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 1 | 78 | 51,295 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 11 | 856 | 195,722 | 195.7 K to 195.7 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 6,506 | 508,342 | 9,094,309 | 9.1 M to 9.1 M (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 999 | 78,056 | 1,437,704 | 1.4 M to 1.4 M (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 172 | 13,439 | 280,108 | 280.3 K to 280.1 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 100 | 7,813 | 179,556 | 179.7 K to 179.6 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 8 | 625 | 51,296 | 51.3 K to 51.3 K (-0.02 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 112 | 8,751 | 195,733 | 195.8 K to 195.7 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 9,100,815 | 9.1 M to 9.1 M (+0.09 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 1,438,703 | 1.4 M to 1.4 M (+0.58 %) |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 27.75 | 3,521 | 97,708 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 27.75 | 3,521 | 97,708 | 0 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 27.75 | 6,479 | 179,792 | 3,521 | |
| Feb 26 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | M | 27.75 | 6,479 | 179,792 | 3,521 |